Topas Therapeutics raised €18M in a Series B round in Jul 2021. The company is based in Hamburg, Germany. Investors in the round: BioMedPartners, Boehringer Ingelheim Venture Fund, EMBL Ventures and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €18M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
